These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19698584)

  • 1. Neurobiologic basis of antidepressant safety profiles.
    Hackett D; Salinas E
    Eur Psychiatry; 1997; 12 Suppl 4():301s-6s. PubMed ID: 19698584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine:a novel antidepressant compound.
    Schweizer E; Thielen RJ; Frazer A
    Expert Opin Investig Drugs; 1997 Jan; 6(1):65-78. PubMed ID: 15989562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy and tolerability of venlafaxine.
    Dierick M
    Eur Psychiatry; 1997; 12 Suppl 4():307s-13s. PubMed ID: 19698585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of venlafaxine in rational antidepressant therapy.
    Feighner JP
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R; Wilde MI
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine: a structurally unique and novel antidepressant.
    Morton WA; Sonne SC; Verga MA
    Ann Pharmacother; 1995 Apr; 29(4):387-95. PubMed ID: 7633018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerance profile of venlafaxine.
    Danjou P; Hackett D
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():15-20. PubMed ID: 7622813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug.
    Kiliç S; Ergin H; Baydinç YC
    Int J Androl; 2005 Feb; 28(1):47-52. PubMed ID: 15679621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desvenlafaxine: another "me too" drug?
    Sopko MA; Ehret MJ; Grgas M
    Ann Pharmacother; 2008 Oct; 42(10):1439-46. PubMed ID: 18698015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
    Serres F; Millan MJ; Sharp T
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):617-29. PubMed ID: 21733241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
    Fava GA; Benasi G; Lucente M; Offidani E; Cosci F; Guidi J
    Psychother Psychosom; 2018; 87(4):195-203. PubMed ID: 30016772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
    Gründer G; Wetzel H; Schlösser R; Benkert O
    Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
    Mendels J; Johnston R; Mattes J; Riesenberg R
    Psychopharmacol Bull; 1993; 29(2):169-74. PubMed ID: 8290661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options for treating major depression, and the role of venlafaxine.
    Scott MA; Shelton PS; Gattis W
    Pharmacotherapy; 1996; 16(3):352-65. PubMed ID: 8726593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapeutic profile of venlafaxine.
    Preskorn S
    Eur Psychiatry; 1997; 12 Suppl 4():285s-94s. PubMed ID: 19698582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administered gabapentin and venlafaxine in nerve injured rats: Effect on mechanical hypersensitivity, motor function and pharmacokinetics.
    Folkesson A; Honoré PH; Bjerrum OJ
    Scand J Pain; 2010 Apr; 1(2):91-97. PubMed ID: 29913946
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.